Views & Analysis Transforming pharma R&D with a scientist-centric approach to... As biopharmaceutical products have become increasingly complex, both in design and in regulatory requirements, we need a new way of working.
Digital BIO-Europe Spring Digital: Big data and AI panel discussion The combination of big data and artificial intelligence/machine learning is a powerful one and nowhere more so than in healthcare.
Digital Now what? The future of clinical trials after the pandemic Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.
Views & Analysis AI, big data and real world evidence – the challenges and op... Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine.
Digital AI in action: Report highlights the real-world benefits of A... Joined up thinking is the key to converting AI-driven advances into real benefits for healthcare systems, say NHSX.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.